HCA
Hyperion Capital Advisors’s ATAI Life Sciences ATAI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $369K | Hold |
168,416
| – | – | 0.23% | 39 |
|
2025
Q1 | $229K | Hold |
168,416
| – | – | 0.12% | 58 |
|
2024
Q4 | $224K | Hold |
168,416
| – | – | 0.12% | 80 |
|
2024
Q3 | $195K | Hold |
168,416
| – | – | 0.09% | 125 |
|
2024
Q2 | $224K | Hold |
168,416
| – | – | 0.11% | 85 |
|
2024
Q1 | $332K | Hold |
168,416
| – | – | 0.16% | 47 |
|
2023
Q4 | $237K | Hold |
168,416
| – | – | 0.13% | 57 |
|
2023
Q3 | $217K | Hold |
168,416
| – | – | 0.12% | 58 |
|
2023
Q2 | $290K | Hold |
168,416
| – | – | 0.16% | 47 |
|
2023
Q1 | $305K | Hold |
168,416
| – | – | 0.15% | 43 |
|
2022
Q4 | $448K | Hold |
168,416
| – | – | 0.22% | 38 |
|
2022
Q3 | $557K | Hold |
168,416
| – | – | 0.27% | 33 |
|
2022
Q2 | $613K | Hold |
168,416
| – | – | 0.29% | 35 |
|
2022
Q1 | $857K | Buy |
+168,416
| New | +$857K | 0.32% | 31 |
|